NSE - Delayed Quote INR
Bafna Pharmaceuticals Limited (BAFNAPH.NS)
80.40
+3.48
+(4.52%)
At close: April 25 at 3:13:46 PM GMT+5:30
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Bansilal Mahaveer Chand Bafna | Chief Executive Officer | -- | -- | 1961 |
| Mr. Melagiri Sridhar | Chief Financial Officer | -- | -- | 1968 |
| Mr. Vinayak Dinesh Dendukuri | Whole-Time Director of Quality | -- | -- | 1987 |
| Ms. Shanmugam Hemalatha | Executive Chairman | -- | -- | 1975 |
| Mr. A. Mohanachandran | Company Secretary & Compliance Officer | -- | -- | -- |
Bafna Pharmaceuticals Limited
Bafna Towers
New No. 68 Old No. 299 Thambu Chetty St
Chennai, 600001
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 363
Description
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.
Corporate Governance
Bafna Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 27, 2025 at 10:59 AM UTC - May 31, 2025 at 12:00 PM UTC
Bafna Pharmaceuticals Limited Earnings Date
Recent Events
September 19, 2013 at 12:00 AM UTC
Ex-Dividend Date